Switching Lamivudine with Adefovir Dipivoxil Combination Therapy to Entecavir Monotherapy Provides Better Viral Suppression and Kidney Safety

Introduction: Most chronic hepatitis B (CHB) patients in China are primitively treated with a combination of lamivudine (LAM) and adefovir dipivoxil (ADV). Although antiviral resistance can be avoided with this combination therapy, using it can have harmful side effects related to ADV, specifically...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Med Sci
Huvudupphovsmän: Lian, Jiang-Shan, Zhang, Xiao-Lin, Lu, Ying-Feng, Chen, Jian-Yang, Zhang, Yi-Min, Jia, Hong-Yu, Zhang, Zhe, Yang, Yi-Da
Materialtyp: Artigo
Språk:Inglês
Publicerad: Ivyspring International Publisher 2019
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6332476/
https://ncbi.nlm.nih.gov/pubmed/30662324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.28700
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk